Order Article Reprints

Claros S, Cabrera P, Valverde N, Romero-Zerbo SY, López-González MV, Shumilov K, Rivera A, Pavia J, Martín-Montañez E, Garcia-Fernandez M. Insulin-like Growth Factor II Prevents MPP+ and Glucocorticoid Mitochondrial-Oxidative and Neuronal Damage in Dopaminergic Neurons. Antioxidants. 2022; 11(1):41. https://doi.org/10.3390/antiox11010041

Claros, Silvia, Pablo Cabrera, Nadia Valverde, Silvana Y. Romero-Zerbo, Manuel Víctor López-González, Kirill Shumilov, Alicia Rivera, Jose Pavia, Elisa Martín-Montañez, and María Garcia-Fernandez. 2022. "Insulin-like Growth Factor II Prevents MPP+ and Glucocorticoid Mitochondrial-Oxidative and Neuronal Damage in Dopaminergic Neurons" Antioxidants 11, no. 1: 41. https://doi.org/10.3390/antiox11010041

Claros, S., Cabrera, P., Valverde, N., Romero-Zerbo, S. Y., López-González, M. V., Shumilov, K., Rivera, A., Pavia, J., Martín-Montañez, E., & Garcia-Fernandez, M. (2022). Insulin-like Growth Factor II Prevents MPP+ and Glucocorticoid Mitochondrial-Oxidative and Neuronal Damage in Dopaminergic Neurons. Antioxidants, 11(1), 41. https://doi.org/10.3390/antiox11010041